TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,265.00
-130.00 (-5.43%)
Oct 8, 2026, 3:30 PM KST

TELCON RF PHARMACEUTICAL. Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
61,78443,16237,86536,30727,83037,841
Revenue Growth
50.63%13.99%4.29%30.46%-26.46%14.18%
Gross Profit
21,49910,12010,2379,5075,5639,061
Operating Income
386.3718.59-70.55965.32-4,063-4,563
Net Income
-17,481-11,456-26,32013,906-42,084-23,098
Earnings Per Share
-2860.86-2390.00-7420.003417.07-13223.92-8764.33
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
RF Business Division
10,5759,98212,77011,81112,40126,433
Pharmaceutical/Bio Business Division
32,45134,72326,87125,89316,48715,232
Elimination of Internal Transactions, Etc.
-1,334-1,543-1,775-1,397-1,058-3,825
Total
61,78443,16237,86536,30727,83037,841

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
36,57832,12510,03710,5199,73423,195
Total Debt
63,14734,26855,69127,42330,27555,936
Net Cash (Debt)
-26,569-2,143-45,654-16,904-20,542-32,741
Net Cash Growth
------
Net Cash Per Share
-4346.05-446.86-12869.32-3767.91-4985.94-12423.17

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,8721,6671,219-1,135-2,093-358.56
Capital Expenditures
-1,825-319.81-4,968-3,820-819.43-2,254
Free Cash Flow
47.071,347-3,749-4,954-2,912-2,613
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
34.80%23.45%27.03%26.19%19.99%23.95%
Operating Margin
0.63%1.67%-0.19%2.66%-14.60%-12.06%
Pretax Margin
-43.77%-26.48%-69.98%38.42%-151.34%-60.45%
Profit Margin
-28.29%-26.54%-69.51%38.30%-151.22%-61.04%
FCF Margin
0.08%3.12%-9.90%-13.64%-10.46%-6.90%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---7.02--
P/FCF Ratio
270.4846.65----
PS Ratio
0.211.461.862.693.966.76